Ipsen Biopharmaceuticals, Inc. v. Xavier Becerra
Ipsen Biopharmaceuticals, Inc. v. Xavier Becerra
108 F.4th 836
(Federal Reporter, Fourth Series)
Cases that cite this one
4 later published cases cite this decision.
- Teva Branded Pharmaceutical Products R&D, Inc. v. Amneal Pharmaceuticals of New York, LLC (Fed. Cir. 2024)
- Healthy Gulf v. Haaland (District Court, District of Columbia 2025)
- Mennonite Church USA v. U.S. Department of Homeland Security (District Court, District of Columbia 2025)
- Novartis Pharmaceuticals Corporation v. Becerra (District Court, District of Columbia 2024)
This list shows which later cases cite this one. It does not say how they treated it, and no review of that has been done. Not a substitute for Shepard’s or KeyCite — verify before relying.
Opinion
United States Court of Appeals FOR THE DISTRICT OF COLUMBIA CIRCUIT ____________ No. 23-5142 September Term, 2023 1:22-cv-00860-DLF Filed On: July 9, 2024 Ipsen Biopharmaceuticals, Inc., Appellant v. Xavier Becerra, in his official capacity as Secretary of Health and Human Services, et al., Appellees
BEFORE: Wilkins, Katsas and Rao, Circuit Judges
UNDER SEAL OPINION NOT AVAILABLE TO PUBLIC
Case-law data current through September 30, 2026. Source: CourtListener bulk data.